Journal article · 2025 · Open access

Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies

Ruoli Wang, Jincheng Zhuang, Qi Zhang, Wantao Wu, Xinrui Yu, Hao Zhang, Zongyi Xie

Experimental Hematology and Oncology, 14(1), 99 · Published 22 July 2025 · DOI 10.1186/s40164-025-00689-6

Open PDFView at the publisherCite this paper

In brief

“Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies” is a 2025 journal article by Ruoli Wang and 6 co-authors, published in Experimental Hematology and Oncology. OpenAlex counts 60 citations as of 18 November 2026, which puts it in the top 4% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Experimental Hematology and Oncology.

Citations
60
Most cited in
2026 (55)
Field-weighted impact
17.35
References
513
Authors
7

Abstract

The tumor microenvironment (TME) represents a metabolic battleground where immune cells and cancer cells vie for essential nutrients, ultimately influencing antitumor immunity and treatment outcomes. Recent advancements have shed light on how the metabolic reprogramming of immune cells, including macrophages, T cells, and DCs, determines their functional polarization, survival, and interactions within the TME. Factors such as hypoxia, acidosis, and nutrient deprivation drive immune cells toward immunosuppressive phenotypes, while metabolic interactions between tumors and stromal cells further entrench therapeutic resistance. This review synthesizes new insights into the metabolic checkpoints that regulate immune cell behavior, focusing on processes like glycolysis, oxidative phosphorylation (OXPHOS), lipid oxidation, and amino acid dependencies. We emphasize how metabolic enzymes (e.g., IDO1, ACLY, CPT1A) and metabolites (e.g., lactate, kynurenine) facilitate immune evasion, and we propose strategies to reverse these pathways. Innovations such as single-cell metabolomics, spatial profiling, and AI-driven drug discovery are transforming our understanding of metabolic heterogeneity and its clinical implications. Furthermore, we discuss cutting-edge therapeutic approaches-from dual-targeting metabolic inhibitors to biomaterial-based delivery systems-that aim to reprogram immune cell metabolism and enhance the effectiveness of immunotherapy. Despite the promise in preclinical studies, challenges persist in translating these findings to clinical applications, including biomarker validation, metabolic plasticity, and interpatient variability. By connecting mechanistic discoveries with translational applications, this review highlights the potential of immunometabolic targeting to overcome resistance and redefine precision oncology.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Wang, R., Zhuang, J., Zhang, Q., Wu, W., Yu, X., Zhang, H., & Xie, Z. (2025). Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies. Experimental Hematology and Oncology, 14(1), 99. https://doi.org/10.1186/s40164-025-00689-6

MLA 9

Wang, Ruoli, et al. “Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies.” Experimental Hematology and Oncology, vol. 14, no. 1, 2025, p. 99. https://doi.org/10.1186/s40164-025-00689-6.

Chicago

Wang, Ruoli, Jincheng Zhuang, Qi Zhang, Wantao Wu, Xinrui Yu, Hao Zhang, and Zongyi Xie. 2025. “Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies.” Experimental Hematology and Oncology 14 (1): 99. https://doi.org/10.1186/s40164-025-00689-6.

Harvard

Wang, R. et al. (2025) ‘Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies’, Experimental Hematology and Oncology, 14(1), p. 99. doi:10.1186/s40164-025-00689-6.

IEEE

R. Wang et al., “Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies,” Experimental Hematology and Oncology, vol. 14, no. 1, p. 99, 2025, doi: 10.1186/s40164-025-00689-6.

BibTeX

@article{wang2025decoding,
  title     = {{Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies}},
  author    = {Wang, Ruoli and Zhuang, Jincheng and Zhang, Qi and Wu, Wantao and Yu, Xinrui and Zhang, Hao and Xie, Zongyi},
  journal   = {Experimental Hematology and Oncology},
  year      = {2025},
  volume    = {14},
  number    = {1},
  pages     = {99},
  doi       = {10.1186/s40164-025-00689-6},
  url       = {https://doi.org/10.1186/s40164-025-00689-6}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202411
202544
20265555

Its field-weighted citation impact is 17.35: it has been cited 17.35 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer

  • tumor microenvironment
  • immunometabolism
  • tumor immune evasion
  • immunosuppression
  • macrophage polarization
  • T cell metabolism
  • dendritic cell metabolism
  • hypoxia

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Wang, R., Zhuang, J., Zhang, Q., Wu, W., Yu, X., Zhang, H., & Xie, Z. (2025). Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies. Experimental Hematology and Oncology, 14(1), 99. https://doi.org/10.1186/s40164-025-00689-6

How many times has this paper been cited?

60 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Experimental Hematology and Oncology: sign in and open the PDF from this page.

Who wrote this paper?

Ruoli Wang, Jincheng Zhuang, Qi Zhang, Wantao Wu, Xinrui Yu, Hao Zhang, Zongyi Xie.

What is the DOI of this paper?

10.1186/s40164-025-00689-6, permanently at https://doi.org/10.1186/s40164-025-00689-6. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.